Vol.

No.

August 05, 2022Aug 05, 2022

Free

DOWNLOAD THE PDF

Three weeks in Mariupol; How Dr. Hanych kept his cancer patients alive amid Russia’s attack

Cover Story

Free

Three weeks in Mariupol; How Dr. Hanych kept his cancer patients alive amid Russia’s attack

By Paul Goldberg

The roof of the Radiation Therapy Department of the Mariupol Municipal Interdistrict Regional Oncologic Dispensary, the parts that aren’t caved in, looks like a sieve.

Free Guest Editorial

How you can help Ukrainian oncology practitioners fight two evils: cancer and war

By Nataliya Kovalchuk, Andriy Beznosenko, Ruslan Zelinsky, Nelya Melnitchouk, Viktor Iakovenko, Roman Kowalchuk, Oleh Duda, Andrii Hanych, Yuliia Severyn, Bohdana Bachynska, Serhii Brovchuk and Natalka Suchowerska

Free Guest Editorial

Cancer research beset by a Gordian Knot of problems

By Wafik S. El-Deiry

Free Guest Editorial

Patient navigation improves outcomes and addresses health equity across the cancer continuum

By Arif Kamal and Tawana Thomas Johnson

Free Guest Editorial

Getting back to where we once belonged
An argument for restoring creative spirit in science

By Jonathan Chernoff

Book Review Free

What are you reading in 2022?

By Katie Goldberg

Free In the Archives

DeVita, Marks, Zubrod: Oral histories with the people who shaped the NCA

In Brief

Wistar receives $5M merit extension award from NCI

RTOG Foundation establishes four new committees; names committee leaders

Nine oncology practices certified through ASCO Patient-Centered Cancer Care Certification pilot

Nicholas Shungu named associate director for DEI at MUSC Hollings

Ju Dong Yang named medical director of the Liver Cancer Program Cedars-Sinai Cancer Center

Nithya Cherukuru named assistant professor at Fox Chase

Malorie K. Simons named assistant professor at Fox Chase

Adam Walchak named assistant professor at Fox Chase

City of Hope receives $7M to study interventions for lung cancer in older adults

Baylor researchers receive five-year, $5.5M NCI grant for liver cancer risk factors and prevention research

Funding Opportunities

Thermo Fisher Scientific opens Oncomine Clinical Research Grant call for submissions; latest awardees announced

DoD Peer Reviewed Cancer Research Program anticipated funding opportunities for the 2022 fiscal year

Clinical Roundup

Subcutaneous formulation of Tecentriq demonstrates positive phase III results

Thermo Fisher introduces assays for MRD detection in myeloid malignancies

Drugs & Targets

Lynparza approved by the EC as adjuvant treatment for high-risk breast cancer

MD Anderson and TransCode Therapeutics collaborate to advance RNA therapies

Poseida, Roche to collaborate on allogeneic CAR T-cell therapies for hematologic malignancies

NCI Trials

NCI Trials for August 2022

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 42 - November 14, 2025

Three weeks in Mariupol; How Dr. Hanych kept his cancer patients alive amid Russia’s attack

How you can help Ukrainian oncology practitioners fight two evils: cancer and war

Cancer research beset by a Gordian Knot of problems

Patient navigation improves outcomes and addresses health equity across the cancer continuum

Getting back to where we once belonged
An argument for restoring creative spirit in science

What are you reading in 2022?

DeVita, Marks, Zubrod: Oral histories with the people who shaped the NCA

In Brief

Wistar receives $5M merit extension award from NCI

RTOG Foundation establishes four new committees; names committee leaders

Nine oncology practices certified through ASCO Patient-Centered Cancer Care Certification pilot

Nicholas Shungu named associate director for DEI at MUSC Hollings

Ju Dong Yang named medical director of the Liver Cancer Program Cedars-Sinai Cancer Center

Nithya Cherukuru named assistant professor at Fox Chase

Malorie K. Simons named assistant professor at Fox Chase

Adam Walchak named assistant professor at Fox Chase

City of Hope receives $7M to study interventions for lung cancer in older adults

Baylor researchers receive five-year, $5.5M NCI grant for liver cancer risk factors and prevention research

Funding Opportunities

Thermo Fisher Scientific opens Oncomine Clinical Research Grant call for submissions; latest awardees announced

DoD Peer Reviewed Cancer Research Program anticipated funding opportunities for the 2022 fiscal year

Clinical Roundup

Subcutaneous formulation of Tecentriq demonstrates positive phase III results

Thermo Fisher introduces assays for MRD detection in myeloid malignancies

Drugs & Targets

Lynparza approved by the EC as adjuvant treatment for high-risk breast cancer

MD Anderson and TransCode Therapeutics collaborate to advance RNA therapies

Poseida, Roche to collaborate on allogeneic CAR T-cell therapies for hematologic malignancies

NCI Trials

NCI Trials for August 2022

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login